JOSHUA CALDWELL: Open Payments
NPI 1124793021 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 44 payments from 13 companies in 2025. Trend: 2023 $589 · 2024 $984 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $222 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $164 |
| GENZYME CORPORATION | 5 | $135 |
| QOL Medical, LLC | 5 | $120 |
| Madrigal Pharmaceuticals | 2 | $76 |
| Celltrion USA Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: XIFAXAN, DUPIXENT, Sucraid, RINVOQ, REZDIFFRA, SKYRIZI, VEGZELMA, CREON.
Industry payments across KY — which companies pay providers there.
